How can patients who are not referred for treatment receive the best treatment available?

Author： Warren Graham W.   Marshall James R.   Cummings K. Michael   Singh Anurag K.   Reid Mary E.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|11|1750-1751

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.11, 2014-06, pp. : 1750-1751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Patients with lung cancer who continue using Avastin [bevacizumab] beyond the median treatment duration will receive the drug free of charge

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Older patients and Black patients are less likely to receive intensive treatment for locoregional oesophageal cancer than younger, White patients

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 534, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Epidemiology and Treatment of Epilepsy in Patients who are Mentally Retarded

By Deb S.  

CNS Drugs, Vol. 13, Iss. 2, 2000-02 ,pp. : 117-128

Adis International

Access to resources Recommend Favorite

Despite guidelines recommending intensive lipid-lowering therapy in patients with ACS, most such patients do not receive such treatment

By  

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Despite guidelines recommending intensive lipid-lowering therapy in patients with ACS, most such patients do not receive such treatment

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 541, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite